Kyntra Bio annual debt-to-equity ratio
2016
2017
2018
2019
2020
2021
Kyntra Bio Debt-to-Equity Ratio Growth & History (KYNB)
Kyntra Bio's debt-to-equity ratio was 0.48 for fiscal 2021.
View full Kyntra Bio company overviewKyntra Bio annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2021 | 2021-12-31 | 0.48 | 0.38 | +406.32% |
| 2020 | 2020-12-31 | 0.09 | −0.01 | −6.31% |
| 2019 | 2019-12-31 | 0.10 | 0.10 | — |
| 2018 | 2018-12-31 | 0.00 | −0.18 | — |
| 2017 | 2017-12-31 | 0.18 | −0.44 | −70.39% |
| 2016 | 2016-12-31 | 0.62 | — | — |
Kyntra Bio quarterly debt-to-equity ratio
Q4.16
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2022 | 2022-09-30 | 3.52 | 3.21 | +1020.72% |
| Q2 2022 | 2022-06-30 | 0.91 | 0.50 | +125.15% |
| Q1 2022 | 2022-03-31 | 0.61 | 0.51 | +472.22% |
| Q4 2021 | 2021-12-31 | 0.48 | 0.38 | +406.32% |
| Q3 2021 | 2021-09-30 | 0.31 | 0.22 | +237.23% |
| Q2 2021 | 2021-06-30 | 0.40 | 0.29 | +252.42% |
| Q1 2021 | 2021-03-31 | 0.11 | 0.00 | +1.22% |
| Q4 2020 | 2020-12-31 | 0.09 | −0.01 | −6.31% |
| Q3 2020 | 2020-09-30 | 0.09 | 0.00 | +0.68% |
| Q2 2020 | 2020-06-30 | 0.11 | 0.02 | +26.58% |
| Q1 2020 | 2020-03-31 | 0.11 | −0.02 | −12.45% |
| Q4 2019 | 2019-12-31 | 0.10 | 0.10 | — |
| Q3 2019 | 2019-09-30 | 0.09 | −0.11 | −55.20% |
| Q2 2019 | 2019-06-30 | 0.09 | −0.11 | −54.10% |
| Q1 2019 | 2019-03-31 | 0.12 | −0.07 | −38.13% |
| Q4 2018 | 2018-12-31 | 0.00 | −0.18 | — |
| Q3 2018 | 2018-09-30 | 0.21 | 0.04 | +21.20% |
| Q2 2018 | 2018-06-30 | 0.20 | — | — |
| Q1 2018 | 2018-03-31 | 0.20 | — | — |
| Q4 2017 | 2017-12-31 | 0.18 | −0.44 | −70.39% |
| Q3 2017 | 2017-09-30 | 0.17 | — | — |
| Q4 2016 | 2016-12-31 | 0.62 | — | — |
Kyntra Bio debt-to-equity ratio trends
Over the last five fiscal years, Kyntra Bio's debt-to-equity ratio decreased from 0.62 to 0.48, a change of −0.15. The latest reported quarter, Q3 2022, shows 3.52.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kyntra Bio source filings ↗